EVACMEDIUM SIGNALFINANCIAL10-Q

EVAC completed its IPO process with the forfeiture of 575,000 founder shares following the expiration of underwriters' over-allotment option on August 17, 2025.

The company has transitioned from pre-IPO status to a public SPAC with $460 million held in trust, establishing its capital base for future business combinations. The forfeiture of founder shares reduces potential dilution and clarifies the final equity structure post-IPO.

Comparing 2025-11-14 vs 2025-08-13View on EDGAR →
FINANCIAL ANALYSIS

The balance sheet reflects EVAC's transition to public company status, with current liabilities declining meaningfully from $395K to $122K as IPO-related obligations were settled. The company now operates as a funded SPAC with substantial trust account proceeds available for acquisitions. The financial position appears stable with reduced near-term liabilities following the completion of the public offering process.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
-69.1%
$395K$122K

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2025-11-14
PRIOR — 2025-08-13
ADDED
(2) Excludes 575,000 Class B ordinary shares forfeited by the Company s Sponsor (Note 7).
As a result of the partial exercise of the over-allotment option by the underwriters, 1,000,000 Founder Shares were no longer subject to forfeiture at such time.
The remaining 575,000 Founder Shares were forfeited on August 17, 2025, the expiration date of the over-allotment option, as the over-allotment option remained unexercised, resulting in the total Class B ordinary shares outstanding decreasing to 11,500,000 (Note 4).
As a result of the partial exercise of the over-allotment option by the underwriters, 1,000,000 Founder Shares were no longer subject to forfeiture at such time.
The remaining 575,000 Founder Shares were forfeited on August 17, 2025, the expiration date of the over-allotment option, as the over-allotment option remained unexercised, resulting in the total Class B ordinary shares outstanding decreasing to 11,500,000 (Note 4).
+7 more — sign up free →
REMOVED
Interim Financial Statements 1 Condensed Balance Sheets as of June 30, 2025 (Unaudited) and December 31, 2024 1 Condensed Statements of Operations for the Three and Six Months Ended June 30, 2025 (Unaudited) 2 Condensed Statements of Changes in Shareholders Deficit for the Three and Six Months Ended June 30, 2025 (Unaudited) 3 Condensed Statement of Cash Flows for the Six Months Ended June 30, 2025 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5 Item 2.
As a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 1,000,000 founder shares are no longer subject to forfeiture, and 575,000 founder shares remain subject to forfeiture if the over-allotment option is not exercised in full by the underwriters (Note 4).
As a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 1,000,000 founder shares are no longer subject to forfeiture, and 575,000 founder shares remain subject to forfeiture if the over-allotment option is not exercised in full by the underwriters (Note 4).
As a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 1,000,000 founder shares are no longer subject to forfeiture, and 575,000 founder shares remain subject to forfeiture if the over-allotment option is not exercised in full by the underwriters (Note 4).
As of June 30, 2025, the Company had not commenced any operations.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →